Global Viral Molecular Diagnostics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 152034
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 123
  • list Medical Devices

Molecular diagnostics refers to a technique used to detect and identify the presence of genetic material or proteins associated with a specific health condition or disease.

Scope of the Report:

North America, followed by Europe, has the largest market for viral molecular diagnostics due to developed healthcare infrastructure, accessibility and affordability of diagnostic tests for viral infectious diseases in this region.

The worldwide market for Viral Molecular Diagnostics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the Viral Molecular Diagnostics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Abbott Laboraories

Bio-Rad Laboratories

Becton, Dickinson

Roche

Gen-Probe

Qiagen

Olympus

Thermo Fisher Scientific

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Hepatitis B Virus (HBV)

Hepatitis C Virus (HCV)

Human Immunodeficiency Virus (HIV)

Human Papillomavirus (HPV)

Market Segment by Applications, can be divided into

Hospitals

Academics Institutions

Laboratories

Others

There are 15 Chapters to deeply display the global Viral Molecular Diagnostics market.

Chapter 1, to describe Viral Molecular Diagnostics Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Viral Molecular Diagnostics, with sales, revenue, and price of Viral Molecular Diagnostics, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Viral Molecular Diagnostics, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Viral Molecular Diagnostics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Viral Molecular Diagnostics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Viral Molecular Diagnostics Introduction

1.2 Market Analysis by Type

1.2.1 Hepatitis B Virus (HBV)

1.2.2 Hepatitis C Virus (HCV)

1.2.3 Human Immunodeficiency Virus (HIV)

1.2.4 Human Papillomavirus (HPV)

1.3 Market Analysis by Applications

1.3.1 Hospitals

1.3.2 Academics Institutions

1.3.3 Laboratories

1.3.4 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Abbott Laboraories

2.1.1 Business Overview

2.1.2 Viral Molecular Diagnostics Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Abbott Laboraories Viral Molecular Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Bio-Rad Laboratories

2.2.1 Business Overview

2.2.2 Viral Molecular Diagnostics Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Bio-Rad Laboratories Viral Molecular Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Becton, Dickinson

2.3.1 Business Overview

2.3.2 Viral Molecular Diagnostics Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Becton, Dickinson Viral Molecular Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Roche

2.4.1 Business Overview

2.4.2 Viral Molecular Diagnostics Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Roche Viral Molecular Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Gen-Probe

2.5.1 Business Overview

2.5.2 Viral Molecular Diagnostics Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Gen-Probe Viral Molecular Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Qiagen

2.6.1 Business Overview

2.6.2 Viral Molecular Diagnostics Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Qiagen Viral Molecular Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Olympus

2.7.1 Business Overview

2.7.2 Viral Molecular Diagnostics Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Olympus Viral Molecular Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Thermo Fisher Scientific

2.8.1 Business Overview

2.8.2 Viral Molecular Diagnostics Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Thermo Fisher Scientific Viral Molecular Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Viral Molecular Diagnostics Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Viral Molecular Diagnostics Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Viral Molecular Diagnostics Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Viral Molecular Diagnostics Manufacturer Market Share in 2017

3.3.2 Top 6 Viral Molecular Diagnostics Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Viral Molecular Diagnostics Market Analysis by Regions

4.1 Global Viral Molecular Diagnostics Sales, Revenue and Market Share by Regions

4.1.1 Global Viral Molecular Diagnostics Sales and Market Share by Regions (2013-2018)

4.1.2 Global Viral Molecular Diagnostics Revenue and Market Share by Regions (2013-2018)

4.2 North America Viral Molecular Diagnostics Sales and Growth Rate (2013-2018)

4.3 Europe Viral Molecular Diagnostics Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Viral Molecular Diagnostics Sales and Growth Rate (2013-2018)

4.5 South America Viral Molecular Diagnostics Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Viral Molecular Diagnostics Sales and Growth Rate (2013-2018)

5 North America Viral Molecular Diagnostics by Countries

5.1 North America Viral Molecular Diagnostics Sales, Revenue and Market Share by Countries

5.1.1 North America Viral Molecular Diagnostics Sales and Market Share by Countries (2013-2018)

5.1.2 North America Viral Molecular Diagnostics Revenue and Market Share by Countries (2013-2018)

5.2 United States Viral Molecular Diagnostics Sales and Growth Rate (2013-2018)

5.3 Canada Viral Molecular Diagnostics Sales and Growth Rate (2013-2018)

5.4 Mexico Viral Molecular Diagnostics Sales and Growth Rate (2013-2018)

6 Europe Viral Molecular Diagnostics by Countries

6.1 Europe Viral Molecular Diagnostics Sales, Revenue and Market Share by Countries

6.1.1 Europe Viral Molecular Diagnostics Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Viral Molecular Diagnostics Revenue and Market Share by Countries (2013-2018)

6.2 Germany Viral Molecular Diagnostics Sales and Growth Rate (2013-2018)

6.3 UK Viral Molecular Diagnostics Sales and Growth Rate (2013-2018)

6.4 France Viral Molecular Diagnostics Sales and Growth Rate (2013-2018)

6.5 Russia Viral Molecular Diagnostics Sales and Growth Rate (2013-2018)

6.6 Italy Viral Molecular Diagnostics Sales and Growth Rate (2013-2018)

7 Asia-Pacific Viral Molecular Diagnostics by Countries

7.1 Asia-Pacific Viral Molecular Diagnostics Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Viral Molecular Diagnostics Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Viral Molecular Diagnostics Revenue and Market Share by Countries (2013-2018)

7.2 China Viral Molecular Diagnostics Sales and Growth Rate (2013-2018)

7.3 Japan Viral Molecular Diagnostics Sales and Growth Rate (2013-2018)

7.4 Korea Viral Molecular Diagnostics Sales and Growth Rate (2013-2018)

7.5 India Viral Molecular Diagnostics Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Viral Molecular Diagnostics Sales and Growth Rate (2013-2018)

8 South America Viral Molecular Diagnostics by Countries

8.1 South America Viral Molecular Diagnostics Sales, Revenue and Market Share by Countries

8.1.1 South America Viral Molecular Diagnostics Sales and Market Share by Countries (2013-2018)

8.1.2 South America Viral Molecular Diagnostics Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Viral Molecular Diagnostics Sales and Growth Rate (2013-2018)

8.3 Argentina Viral Molecular Diagnostics Sales and Growth Rate (2013-2018)

8.4 Colombia Viral Molecular Diagnostics Sales and Growth Rate (2013-2018)

9 Middle East and Africa Viral Molecular Diagnostics by Countries

9.1 Middle East and Africa Viral Molecular Diagnostics Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Viral Molecular Diagnostics Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Viral Molecular Diagnostics Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Viral Molecular Diagnostics Sales and Growth Rate (2013-2018)

9.3 UAE Viral Molecular Diagnostics Sales and Growth Rate (2013-2018)

9.4 Egypt Viral Molecular Diagnostics Sales and Growth Rate (2013-2018)

9.5 Nigeria Viral Molecular Diagnostics Sales and Growth Rate (2013-2018)

9.6 South Africa Viral Molecular Diagnostics Sales and Growth Rate (2013-2018)

10 Global Viral Molecular Diagnostics Market Segment by Type

10.1 Global Viral Molecular Diagnostics Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Viral Molecular Diagnostics Sales and Market Share by Type (2013-2018)

10.1.2 Global Viral Molecular Diagnostics Revenue and Market Share by Type (2013-2018)

10.2 Hepatitis B Virus (HBV) Sales Growth and Price

10.2.1 Global Hepatitis B Virus (HBV) Sales Growth (2013-2018)

10.2.2 Global Hepatitis B Virus (HBV) Price (2013-2018)

10.3 Hepatitis C Virus (HCV) Sales Growth and Price

10.3.1 Global Hepatitis C Virus (HCV) Sales Growth (2013-2018)

10.3.2 Global Hepatitis C Virus (HCV) Price (2013-2018)

10.4 Human Immunodeficiency Virus (HIV) Sales Growth and Price

10.4.1 Global Human Immunodeficiency Virus (HIV) Sales Growth (2013-2018)

10.4.2 Global Human Immunodeficiency Virus (HIV) Price (2013-2018)

10.5 Human Papillomavirus (HPV) Sales Growth and Price

10.5.1 Global Human Papillomavirus (HPV) Sales Growth (2013-2018)

10.5.2 Global Human Papillomavirus (HPV) Price (2013-2018)

11 Global Viral Molecular Diagnostics Market Segment by Application

11.1 Global Viral Molecular Diagnostics Sales Market Share by Application (2013-2018)

11.2 Hospitals Sales Growth (2013-2018)

11.3 Academics Institutions Sales Growth (2013-2018)

11.4 Laboratories Sales Growth (2013-2018)

11.5 Others Sales Growth (2013-2018)

12 Viral Molecular Diagnostics Market Forecast (2018-2023)

12.1 Global Viral Molecular Diagnostics Sales, Revenue and Growth Rate (2018-2023)

12.2 Viral Molecular Diagnostics Market Forecast by Regions (2018-2023)

12.2.1 North America Viral Molecular Diagnostics Market Forecast (2018-2023)

12.2.2 Europe Viral Molecular Diagnostics Market Forecast (2018-2023)

12.2.3 Asia-Pacific Viral Molecular Diagnostics Market Forecast (2018-2023)

12.2.4 South America Viral Molecular Diagnostics Market Forecast (2018-2023)

12.2.5 Middle East and Africa Viral Molecular Diagnostics Market Forecast (2018-2023)

12.3 Viral Molecular Diagnostics Market Forecast by Type (2018-2023)

12.3.1 Global Viral Molecular Diagnostics Sales Forecast by Type (2018-2023)

12.3.2 Global Viral Molecular Diagnostics Market Share Forecast by Type (2018-2023)

12.4 Viral Molecular Diagnostics Market Forecast by Application (2018-2023)

12.4.1 Global Viral Molecular Diagnostics Sales Forecast by Application (2018-2023)

12.4.2 Global Viral Molecular Diagnostics Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Viral Molecular Diagnostics Picture

Table Product Specifications of Viral Molecular Diagnostics

Figure Global Sales Market Share of Viral Molecular Diagnostics by Ty

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery